{"transactions":[{"id":726269,"issuer":{"id":7011,"kind":"organization","name":"MEDICINOVA INC"},"owners":[{"id":35347,"kind":"person","name":"Lemerond Nicole","position":1,"cik":"0001941712","reported_name":"Lemerond Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-25T20:35:06.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":44500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal installments on September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027, subject to continued service with the Company."}],"balance_after":44500,"derivative":{"exercise_price":1.36,"expiration_date":"2036-06-22","underlying":"Common Stock","underlying_shares":44500},"source":{"system":"sec-edgar","filing":"0001683168-26-005110","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226616/000168316826005110/ownership.xml","form_type":"4"}},{"id":731248,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":35347,"kind":"person","name":"Lemerond Nicole","position":1,"cik":"0001941712","reported_name":"Lemerond Nicole","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-06-22T20:20:38.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6000,"derivative":{"exercise_price":1.18,"exercise_date":"2027-06-17","expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001437749-26-021320","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926021320/rdgdoc.xml","form_type":"4"}},{"id":961745,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":35347,"kind":"person","name":"Lemerond Nicole","position":1,"cik":"0001941712","reported_name":"Lemerond Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-19T16:42:35.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/19/2025 and will vest 100% on the one-year anniversary of the grant date (December 18, 2026) or immediately prior to the next Annual General Meeting, whichever is sooner."}],"balance_after":2725,"derivative":{"exercise_price":1.29,"expiration_date":"2030-12-18","underlying":"Common shares","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001213900-25-123637","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025123637/ownership.xml","form_type":"4"}},{"id":1104832,"issuer":{"id":7011,"kind":"organization","name":"MEDICINOVA INC"},"owners":[{"id":35347,"kind":"person","name":"Lemerond Nicole","position":1,"cik":"0001941712","reported_name":"Lemerond Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:11:16.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal installments on September 30, 2025, December 31,2025, March 31,2026 and June 30,2026, subject to continued service with the Company."}],"balance_after":20000,"derivative":{"exercise_price":1.26,"expiration_date":"2035-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001683168-25-004649","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226616/000168316825004649/ownership.xml","form_type":"4"}},{"id":1120475,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":35347,"kind":"person","name":"Lemerond Nicole","position":1,"cik":"0001941712","reported_name":"Lemerond Nicole","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-06-06T13:51:40.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan.  Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."}],"balance_after":10000,"derivative":{"exercise_price":2.48,"exercise_date":"2026-01-02","expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-25-019644","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925019644/rdgdoc.xml","form_type":"4"}},{"id":1266935,"issuer":{"id":7011,"kind":"organization","name":"MEDICINOVA INC"},"owners":[{"id":35347,"kind":"person","name":"Lemerond Nicole","position":1,"cik":"0001941712","reported_name":"Lemerond Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-14T21:51:32.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":24500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal installments on May 12, 2025, August 12, 2025, November 12,2025 and February 12, 2026, subject to continued service with the Company."}],"balance_after":24500,"derivative":{"exercise_price":1.84,"expiration_date":"2035-02-11","underlying":"Common Stock","underlying_shares":24500},"source":{"system":"sec-edgar","filing":"0001683168-25-001046","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226616/000168316825001046/ownership.xml","form_type":"4"}},{"id":1322543,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":35347,"kind":"person","name":"Lemerond Nicole","position":1,"cik":"0001941712","reported_name":"Lemerond Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-12-23T14:25:28.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/20/2024 and will vest 100% on the one-year anniversary of the grant date (December 19, 2025) or immediately prior to the next Annual General Meeting, whichever is sooner."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split."}],"balance_after":975,"derivative":{"exercise_price":4.14,"expiration_date":"2029-12-19","underlying":"Common shares","underlying_shares":550},"source":{"system":"sec-edgar","filing":"0001213900-24-111566","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390024111566/ownership.xml","form_type":"4"}},{"id":1434192,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":35347,"kind":"person","name":"Lemerond Nicole","position":1,"cik":"0001941712","reported_name":"Lemerond Nicole","relationship":{"director":true}}],"security":"Stock Option","published_at":"2024-08-14T20:07:59.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":8050,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8050,"derivative":{"exercise_price":2.17,"exercise_date":"2025-08-12","expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":8050},"source":{"system":"sec-edgar","filing":"0001437749-24-026791","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924026791/rdgdoc.xml","form_type":"4"}},{"id":1481844,"issuer":{"id":7011,"kind":"organization","name":"MEDICINOVA INC"},"owners":[{"id":35347,"kind":"person","name":"Lemerond Nicole","position":1,"cik":"0001941712","reported_name":"Lemerond Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-12T23:40:36.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025, subject to continued service with the Company."}],"balance_after":20000,"derivative":{"exercise_price":1.34,"expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001683168-24-004155","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226616/000168316824004155/ownership.xml","form_type":"4"}},{"id":1699948,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":35347,"kind":"person","name":"Lemerond Nicole","position":1,"cik":"0001941712","reported_name":"Lemerond Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-26T18:09:25.000Z","date":"2023-12-23","kind":"grant","planned":false,"acquired":true,"shares":7100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/23/2023 and will vest 100% on the one-year anniversary of the grant date (December 23, 2024) or immediately prior to the next Annual General Meeting, whichever is sooner."}],"balance_after":8500,"derivative":{"exercise_price":0.37,"expiration_date":"2028-12-22","underlying":"Common shares","underlying_shares":7100},"source":{"system":"sec-edgar","filing":"0001213900-23-098495","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390023098495/ownership.xml","form_type":"4"}},{"id":1809182,"issuer":{"id":8419,"kind":"organization","name":"GeoVax Labs, Inc."},"owners":[{"id":35347,"kind":"person","name":"Lemerond Nicole","position":1,"cik":"0001941712","reported_name":"Lemerond Nicole","relationship":{"director":true}}],"security":"Stock Option","published_at":"2023-08-14T20:52:05.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date.  The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan.  Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance."}],"balance_after":50000,"derivative":{"exercise_price":0.755,"exercise_date":"2023-12-07","expiration_date":"2033-12-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-23-023741","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923023741/rdgdoc.xml","form_type":"4"}},{"id":1812815,"issuer":{"id":7011,"kind":"organization","name":"MEDICINOVA INC"},"owners":[{"id":35347,"kind":"person","name":"Lemerond Nicole","position":1,"cik":"0001941712","reported_name":"Lemerond Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-08T20:18:15.000Z","date":"2023-08-04","kind":"grant","planned":false,"acquired":true,"shares":18333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, subject to continued service with the Company."}],"balance_after":18333,"derivative":{"exercise_price":2.47,"expiration_date":"2033-08-03","underlying":"Common Stock","underlying_shares":18333},"source":{"system":"sec-edgar","filing":"0001683168-23-005416","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226616/000168316823005416/ownership.xml","form_type":"4"}},{"id":2081015,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":35347,"kind":"person","name":"Lemerond Nicole","position":1,"cik":"0001941712","reported_name":"Lemerond Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-12-19T22:08:34.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/16/2022 and will vest as follows: Vesting 100% on the one-year anniversary of the grant date (Dec 16, 2023) or immediately prior to the next AGM, whichever is sooner."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split."}],"balance_after":1400,"derivative":{"exercise_price":1.78,"expiration_date":"2027-12-15","underlying":"Common shares","underlying_shares":840},"source":{"system":"sec-edgar","filing":"0001213900-22-080987","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390022080987/ownership.xml","form_type":"4"}},{"id":2188960,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":35347,"kind":"person","name":"Lemerond Nicole","position":1,"cik":"0001941712","reported_name":"Lemerond Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-08-11T00:14:31.000Z","date":"2022-08-10","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on Aug 10, 2022 and will vest monthly, in arrears, as follows: (i) 390 stock options will vest on the 10th day of each month for 35 months, and (ii) 350 stock options will vest on Aug 10, 2025 (the three year anniversary of Grant date)."}],"balance_after":14000,"derivative":{"exercise_price":0.39,"expiration_date":"2027-08-10","underlying":"Common shares","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001213900-22-046530","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390022046530/ownership.xml","form_type":"4"}}]}